サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1746526

日本の敗血症診断市場レポート：診断別、製品別、検査方法別、技術別、病原体別、エンドユーザー別、地域別、2025～2033年

Japan Sepsis Diagnostics Market Report by Diagnosis, Product, Mode of Testing, Technology, Pathogen, End User, and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 122 Pages
納期
5～7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円
日本の敗血症診断市場レポート：診断別、製品別、検査方法別、技術別、病原体別、エンドユーザー別、地域別、2025～2033年
出版日: 2025年06月02日
発行: IMARC
ページ情報: 英文 122 Pages
納期: 5～7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本の敗血症診断市場規模は2024年に2,410万米ドルに達しました。今後、IMARC Groupは、同市場が2033年までに4,850万米ドルに達し、2025～2033年にかけて7.4%の成長率（CAGR）を示すと予測しています。一般に、異なるプラットフォームからの複数の検査結果の統合を可能にし、リアルタイムのデータアクセスと正確な疾患診断を提供する高度なデータ分析ツールの採用が増加していることが、主に市場の成長を促進しています。

本レポートで扱う主な質問

  • 日本の敗血症診断市場はこれまでどのように推移し、今後どのように推移するのか？
  • COVID-19が日本の敗血症診断市場に与えた影響は？
  • 日本の敗血症診断市場の診断別区分は？
  • 日本の敗血症診断市場の製品別区分は？
  • 日本の敗血症診断市場の検査方法別区分は？
  • 日本の敗血症診断市場の技術別区分は？
  • 日本の敗血症診断市場の病原体別区分は？
  • 日本の敗血症診断市場のエンドユーザー別区分は？
  • 日本の敗血症診断市場のバリューチェーンにおける様々なステージとは？
  • 日本の敗血症診断市場の主要な促進要因と課題は何か？
  • 日本の敗血症診断市場の構造と主要プレーヤーは？
  • 日本の敗血症診断市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 日本の敗血症診断市場-イントロダクション

  • 概要
  • 市場力学
  • 業界動向
  • 競合情報

第5章 日本の敗血症診断市場情勢

  • 過去および現在の市場動向（2019～2024年）
  • 市場予測（2025～2033年）

第6章 日本の敗血症診断市場- 診断別

  • 自動診断
  • 従来型診断

第7章 日本の敗血症診断市場- 製品別

  • 機器
  • アッセイキットと試薬
  • 血液培養培地
  • ソフトウェア

第8章 日本の敗血症診断市場- 検査方法別

  • 臨床検査
  • ポイントオブケア検査

第9章 日本の敗血症診断市場- 技術別

  • 分子診断
  • 免疫測定
  • バイオマーカー
  • フローサイトメトリー
  • マイクロ流体工学
  • 血液培養

第10章 日本の敗血症診断市場- 病原体別

  • 細菌性敗血症
  • ウイルス性敗血症
  • 真菌性敗血症
  • その他

第11章 日本の敗血症診断市場- エンドユーザー別

  • 診断クリニック
  • 病院
  • 研究室

第12章 日本の敗血症診断市場-競合情勢

  • 概要
  • 市場構造
  • 市場企業のポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第13章 主要企業のプロファイル

第14章 日本の敗血症診断市場- 業界分析

  • 促進要因・抑制要因・機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第15章 付録

目次
Product Code: SR112025A18716

Japan sepsis diagnostics market size reached USD 24.1 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 48.5 Million by 2033, exhibiting a growth rate (CAGR) of 7.4% during 2025-2033. The increasing adoption of advanced data analytics tools that generally enable the integration of multiple test results from different platforms to offer real-time data access and accurate disease diagnosis is primarily driving the market growth.

Sepsis is a medical condition that arises as a response of the body when it attempts to combat infections caused by the presence of bacteria, viruses, or fungi. In this state, the immune system releases various chemicals into the bloodstream, setting off excessive inflammation and the formation of blood clots throughout the body. Sepsis can lead to the failure of multiple organs, irregular breathing, low blood pressure, neurological dysfunction, an elevated heart rate, and more. The diagnostic methods for detecting sepsis primarily encompass molecular diagnosis, immunoassays, microfluidics, biomarkers, flow cytometry, and similar technologies. These diagnostic techniques see widespread use in various healthcare settings, including hospitals, pathology laboratories, reference laboratories, and academic research institutions, among others.

Japan Sepsis Diagnostics Market Trends:

In the Japanese market, the surge in demand for sepsis diagnostics can be attributed to several key factors. Firstly, there is a noticeable increase in hospital-acquired infections (HAIs) that can lead to sepsis, particularly among vulnerable demographic groups such as the elderly, infants, and patients with chronic ailments. This trend is a driving force behind the need for improved sepsis diagnostic tools. Secondly, the growing instances of infectious diseases caused by antibiotic-resistant bacteria, including both gram-positive bacteria and gram-negative bacilli, are contributing to the heightened demand for sepsis diagnostics in Japan. These antibiotic-resistant strains require accurate and timely diagnosis for effective treatment. Furthermore, Japan's expanding healthcare sector, coupled with the widespread adoption of advanced data analytics tools, is playing a significant role in catalyzing the growth of the sepsis diagnostics market. These tools enable the integration of diverse test results from various platforms, offering real-time access to critical data and precise disease diagnosis. Additionally, continuous technological advancements have led to the development of new immunological and molecular biomarkers, facilitating early sepsis detection. Investment in extensive research and development activities, including innovative blood culture methods for identifying and managing chronic infections, is expected to contribute to the expansion of the sepsis diagnostics market in Japan over the forecasted period.

Japan Sepsis Diagnostics Market Segmentation:

Diagnosis Insights:

  • Automated Diagnostics
  • Conventional Diagnostics

Product Insights:

  • Instruments
  • Assay Kits and Reagents
  • Blood Culture Media
  • Software

Mode of Testing Insights:

  • Laboratory Tests
  • Point-of-Care Tests

Technology Insights:

  • Molecular Diagnostics
  • Immunoassays
  • Biomarkers
  • Flow Cytometry
  • Microfluidics
  • Blood Culture

Pathogen Insights:

  • Bacterial Sepsis
    • Gram-Positive Bacterial Sepsis
    • Gram-Negative Bacterial Sepsis
  • Viral Sepsis
  • Fungal Sepsis
  • Others

End User Insights:

  • Diagnostic Clinics
  • Hospitals
  • Research Laboratories

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan sepsis diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan sepsis diagnostics market?
  • What is the breakup of the Japan sepsis diagnostics market on the basis of diagnosis?
  • What is the breakup of the Japan sepsis diagnostics market on the basis of product?
  • What is the breakup of the Japan sepsis diagnostics market on the basis of mode of testing?
  • What is the breakup of the Japan sepsis diagnostics market on the basis of technology?
  • What is the breakup of the Japan sepsis diagnostics market on the basis of pathogen?
  • What is the breakup of the Japan sepsis diagnostics market on the basis of end User?
  • What are the various stages in the value chain of the Japan sepsis diagnostics market?
  • What are the key driving factors and challenges in the Japan sepsis diagnostics?
  • What is the structure of the Japan sepsis diagnostics market and who are the key players?
  • What is the degree of competition in the Japan sepsis diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Sepsis Diagnostics Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Sepsis Diagnostics Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Sepsis Diagnostics Market - Breakup by Diagnosis

  • 6.1 Automated Diagnostics
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Conventional Diagnostics
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)

7 Japan Sepsis Diagnostics Market - Breakup by Product

  • 7.1 Instruments
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Assay Kits and Reagents
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Blood Culture Media
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)
  • 7.4 Software
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2019-2024)
    • 7.4.3 Market Forecast (2025-2033)

8 Japan Sepsis Diagnostics Market - Breakup by Mode of Testing

  • 8.1 Laboratory Tests
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Point-of-Care Tests
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)

9 Japan Sepsis Diagnostics Market - Breakup by Technology

  • 9.1 Molecular Diagnostics
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2019-2024)
    • 9.1.3 Market Forecast (2025-2033)
  • 9.2 Immunoassays
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2019-2024)
    • 9.2.3 Market Forecast (2025-2033)
  • 9.3 Biomarkers
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2019-2024)
    • 9.3.3 Market Forecast (2025-2033)
  • 9.4 Flow Cytometry
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2019-2024)
    • 9.4.3 Market Forecast (2025-2033)
  • 9.5 Microfluidics
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2019-2024)
    • 9.5.3 Market Forecast (2025-2033)
  • 9.6 Blood Culture
    • 9.6.1 Overview
    • 9.6.2 Historical and Current Market Trends (2019-2024)
    • 9.6.3 Market Forecast (2025-2033)

10 Japan Sepsis Diagnostics Market - Breakup by Pathogen

  • 10.1 Bacterial Sepsis
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2019-2024)
    • 10.1.3 Market Segmentation
      • 10.1.3.1 Gram-Positive Bacterial Sepsis
      • 10.1.3.2 Gram-Negative Bacterial Sepsis
    • 10.1.4 Market Forecast (2025-2033)
  • 10.2 Viral Sepsis
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2019-2024)
    • 10.2.3 Market Forecast (2025-2033)
  • 10.3 Fungal Sepsis
    • 10.3.1 Overview
    • 10.3.2 Historical and Current Market Trends (2019-2024)
    • 10.3.3 Market Forecast (2025-2033)
  • 10.4 Others
    • 10.4.1 Historical and Current Market Trends (2019-2024)
    • 10.4.2 Market Forecast (2025-2033)

11 Japan Sepsis Diagnostics Market - Breakup by End User

  • 11.1 Diagnostic Clinics
    • 11.1.1 Overview
    • 11.1.2 Historical and Current Market Trends (2019-2024)
    • 11.1.3 Market Forecast (2025-2033)
  • 11.2 Hospitals
    • 11.2.1 Overview
    • 11.2.2 Historical and Current Market Trends (2019-2024)
    • 11.2.3 Market Forecast (2025-2033)
  • 11.3 Research Laboratories
    • 11.3.1 Overview
    • 11.3.2 Historical and Current Market Trends (2019-2024)
    • 11.3.3 Market Forecast (2025-2033)

12 Japan Sepsis Diagnostics Market - Competitive Landscape

  • 12.1 Overview
  • 12.2 Market Structure
  • 12.3 Market Player Positioning
  • 12.4 Top Winning Strategies
  • 12.5 Competitive Dashboard
  • 12.6 Company Evaluation Quadrant

13 Profiles of Key Players

  • 13.1 Company A
    • 13.1.1 Business Overview
    • 13.1.2 Services Offered
    • 13.1.3 Business Strategies
    • 13.1.4 SWOT Analysis
    • 13.1.5 Major News and Events
  • 13.2 Company B
    • 13.2.1 Business Overview
    • 13.2.2 Services Offered
    • 13.2.3 Business Strategies
    • 13.2.4 SWOT Analysis
    • 13.2.5 Major News and Events
  • 13.3 Company C
    • 13.3.1 Business Overview
    • 13.3.2 Services Offered
    • 13.3.3 Business Strategies
    • 13.3.4 SWOT Analysis
    • 13.3.5 Major News and Events
  • 13.4 Company D
    • 13.4.1 Business Overview
    • 13.4.2 Services Offered
    • 13.4.3 Business Strategies
    • 13.4.4 SWOT Analysis
    • 13.4.5 Major News and Events
  • 13.5 Company E
    • 13.5.1 Business Overview
    • 13.5.2 Services Offered
    • 13.5.3 Business Strategies
    • 13.5.4 SWOT Analysis
    • 13.5.5 Major News and Events

14 Japan Sepsis Diagnostics Market - Industry Analysis

  • 14.1 Drivers, Restraints, and Opportunities
    • 14.1.1 Overview
    • 14.1.2 Drivers
    • 14.1.3 Restraints
    • 14.1.4 Opportunities
  • 14.2 Porters Five Forces Analysis
    • 14.2.1 Overview
    • 14.2.2 Bargaining Power of Buyers
    • 14.2.3 Bargaining Power of Suppliers
    • 14.2.4 Degree of Competition
    • 14.2.5 Threat of New Entrants
    • 14.2.6 Threat of Substitutes
  • 14.3 Value Chain Analysis

15 Appendix